AbbVie Inc. (ABBV) Stock Analysis

Free AI-powered analysis and research for AbbVie Inc. stock

Sector: Healthcare

Analyze AbbVie Inc. (ABBV) Stock

AbbVie Inc. (ABBV) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into ABBV stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for AbbVie Inc. stock.

Analyze ABBV Now →

📰 Latest Update

Bank of America Upgrades AbbVie (ABBV) on Skyrizi Strength, Lifts PT

Thu, April 30, 2026 at 11:21 PM UTC 3 min read

Bank of America has upgraded AbbVie (ABBV) due to the strong performance of its psoriasis treatment, Skyrizi, which is expected to drive significant revenue growth. The firm has also raised its price target for the stock, reflecting increased confidence in AbbVie's product pipeline and market position. This upgrade is important for investors as it signals potential upside in AbbVie's stock value, driven by robust sales forecasts for key therapies.

Read full article →